Cargando…
Case Report of Thymoma Tumor Reduction Following Plasmapheresis
For thymoma, multidisciplinary antitumor strategy is composed of surgery, chemotherapy, and radiotherapy. Meanwhile, ∼20% to 25% of patients with thymoma have myasthenia gravis and plasmapheresis is recommended for thymoma-associated myasthenia gravis. We report a case that a 40-year-old woman with...
Autores principales: | Jiang, Wei, Yu, Qitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059021/ https://www.ncbi.nlm.nih.gov/pubmed/26632752 http://dx.doi.org/10.1097/MD.0000000000002173 |
Ejemplares similares
-
An unusual huge thymoma composed of sclerosing thymoma and type AB thymoma: A case report
por: Jiang, Yu-ting, et al.
Publicado: (2021) -
Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report
por: Liu, Shiwei, et al.
Publicado: (2022) -
Graft-versus-host disease-like erythroderma: a sign of recurrent thymoma: A case report
por: Gui, Xiujuan, et al.
Publicado: (2017) -
Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
por: Yoo, Shin Hye, et al.
Publicado: (2017) -
Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report
por: Wang, Chen, et al.
Publicado: (2023)